Results 151 to 160 of about 2,731,118 (178)
The IS<i>Vsa3</i>-ORF2-<i>abh</i>-<i>tet</i>(X4) circular intermediate-mediated transmission of tigecycline resistance in <i>Escherichia coli</i> isolates from duck farms. [PDF]
Jiang C +7 more
europepmc +1 more source
Uncovering the environmental dissemination of mobile tigecycline resistance
William Calero-Cáceres +8 more
openaire +1 more source
[Bacterial resistance and a new antibiotic: tigecycline].
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Emergence of Clinical Resistance to Tigecycline
International Journal of Antimicrobial Agents, 2013Tigecycline (TIG) exhibits broad-spectrum activity against many Gram-positive and Gram-negative pathogens. However, clinical resistance has emerged recently and has been detected following treatment with TIG. This observation suggests that long-term monotherapy may carry a high risk for TIG resistance.
Yun Cai, Rui Wang, Xu Liu
exaly +3 more sources
[[abstract]]Objectives: Tigecycline non-susceptible Acinetobacter nosocomialis (TNAN) has been discovered in clinical isolates. The resistance-nodulation-cell division (RND)-type efflux system plays a major role in tigecycline non-susceptible ...
Jun-Ren Sun, T -L Chen, S -C Kuo
exaly +2 more sources
During the past decades, rates of multidrug-resistant (MDR) and carbapenem-resistant (CR) Enterobacteriaceae clinical isolates, mainly Klebsiella spp., Escherichia coli, Enterobacter spp., Proteus spp.
Spyros Pournaras +2 more
exaly +2 more sources
[[abstract]]Tigecycline is regarded as a last-resort treatment for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections, but increasing numbers of tigecycline-resistant K. pneumoniae isolates have been reported.
Feng-Yee Chang +2 more
exaly +2 more sources
International Journal of Antimicrobial Agents, 2023
Tigecycline heteroresistance is highly prevalent in Acinetobacter baumannii clinical isolates, reducing the efficacy of tigecycline treatment. This study investigated the population dynamics of A. baumannii with tigecycline heteroresistance to determine the origin of resistance that occurs over time after antibiotic exposure.
Jeongwoo Jo +3 more
openaire +2 more sources
Tigecycline heteroresistance is highly prevalent in Acinetobacter baumannii clinical isolates, reducing the efficacy of tigecycline treatment. This study investigated the population dynamics of A. baumannii with tigecycline heteroresistance to determine the origin of resistance that occurs over time after antibiotic exposure.
Jeongwoo Jo +3 more
openaire +2 more sources
RshA mutations contributing to tigecycline resistance in Mycobacteroides abscessus
Journal of Medical Microbiology, 2022Tigecycline is an important rescue antibiotic for many bacterial infections. In Mycobacteroides abscessus , tigecycline resistance has been associated with dysregulated stress response caused by aberrations in the interaction of the SigH and RshA factors.
Kar Men Aw +4 more
openaire +2 more sources
Update on Prevalence and Mechanisms of Resistance to Linezolid, Tigecycline and Daptomycin in Enterococci in Europe: Towards a Common Nomenclature [PDF]
International audienceVancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail.
Jennifer K Bender +2 more
exaly +2 more sources

